These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 28178187)

  • 1. May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.
    Brookhouser N; Raman S; Potts C; Brafman DA
    Cells; 2017 Feb; 6(1):. PubMed ID: 28178187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.
    Pu J; Frescas D; Zhang B; Feng J
    Exp Biol Med (Maywood); 2015 Aug; 240(8):1065-70. PubMed ID: 25956682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Applications of ZFN, TALEN and CRISPR/Cas9 techniques in disease modeling and gene therapy].
    Zhao G; Pu J; Tang B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):857-862. PubMed ID: 27984622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome editing in fishes and their applications.
    Zhu B; Ge W
    Gen Comp Endocrinol; 2018 Feb; 257():3-12. PubMed ID: 28919449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
    Merkert S; Martin U
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in genome editing technology and its promising application in evolutionary and ecological studies.
    Chen L; Tang L; Xiang H; Jin L; Li Q; Dong Y; Wang W; Zhang G
    Gigascience; 2014; 3():24. PubMed ID: 25414792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.
    Li M; Suzuki K; Kim NY; Liu GH; Izpisua Belmonte JC
    J Biol Chem; 2014 Feb; 289(8):4594-9. PubMed ID: 24362028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing for the Study of Cardiovascular Diseases.
    Chadwick AC; Musunuru K
    Curr Cardiol Rep; 2017 Mar; 19(3):22. PubMed ID: 28220462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications.
    Chang CY; Ting HC; Su HL; Jeng JR
    Cell Transplant; 2018 Mar; 27(3):379-392. PubMed ID: 29806481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From hacking the human genome to editing organs.
    Tobita T; Guzman-Lepe J; Collin de l'Hortet A
    Organogenesis; 2015; 11(4):173-82. PubMed ID: 26588350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
    Hendriks WT; Jiang X; Daheron L; Cowan CA
    Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome editing with engineered nucleases in plants.
    Osakabe Y; Osakabe K
    Plant Cell Physiol; 2015 Mar; 56(3):389-400. PubMed ID: 25416289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research advance and application in the gene therapy of gene editing technologies].
    Ren YX; Xiao RD; Lou XM; Fang XD
    Yi Chuan; 2019 Jan; 41(1):18-27. PubMed ID: 30686782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed nucleases for targeted genome editing.
    Lee J; Chung JH; Kim HM; Kim DW; Kim H
    Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endonucleases: new tools to edit the mouse genome.
    Wijshake T; Baker DJ; van de Sluis B
    Biochim Biophys Acta; 2014 Oct; 1842(10):1942-1950. PubMed ID: 24794718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.
    Yu KR; Natanson H; Dunbar CE
    Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9.
    LaFountaine JS; Fathe K; Smyth HD
    Int J Pharm; 2015 Oct; 494(1):180-94. PubMed ID: 26278489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering.
    Gähwiler EKN; Motta SE; Martin M; Nugraha B; Hoerstrup SP; Emmert MY
    Front Cell Dev Biol; 2021; 9():639699. PubMed ID: 34262897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.